Scientific Advisory Panel on Isotretinoin Risk Management (SAP-IRM)
Agenda
Place: Room 2048, 2nd floor, Tower B, Holland Cross, 1600 Scott Street Ottawa
Date and Time: November 17, 2107, 9:00am to 3:00pm, EST
Chairperson: Neil Shear
Science Advisor: Conrad Pereira
Science and Regulatory Affairs Supervisor: Larissa Lefebvre
Participants: SAP-IRM members and Health Canada employees
November 17, 2017
- 09:00-09:15Footnote * - Welcome and Opening remarks, Megan Bettle, Acting Director General, Marketed Health Products Directorate (MHPD)
- 09:15-09:30 - Introduction of Members, Review of Affiliations and Interests Declarations, Chair’s address, Review of Agenda, Chair
- 09:30-10:30 - Health Canada presentation, Marketed Pharmaceuticals and Medical Devices Bureau, MHPD
- 10:30-12:00 - Deliberations of Questions and Answers, SAP-IRM members
- 12:00-12:45 - Lunch
- 12:45-14:45 - Deliberations of Questions and Answers, SAP-IRM members
- 14:45-15:00 - Closing Remarks and Adjournment of Meeting, Chair
Report a problem or mistake on this page
- Date modified: